Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

Overexpression of PARG deregulates epigenetic modifications in breast cancer

FY 2011-12

Summary
Cancer is characterized by abnormal, uncontrolled division of cells. This is the result of a change analogous to 'stepping on the accelerator', or alternatively, losing the 'brake' controlling growth. Recent evidence has shown that one of the initiating steps towards breast cancer is the loss of some of these 'brakes'. Although our DNA cannot easily be reverted to its initial condition once altered to its diseased state, a new branch of research has suggested that we can activate or inactivate targets that have been modified. Applying the knowledge of this new field, we hope to study a target (PARG) we think is highly expressed in cancer and causes the silencing/inactivation of the 'brakes' referred to above. If inhibited with a drug, PARG is likely to restore the expression of the brake, reducing cell growth and ultimately help increase breast cancer survival.
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
252432
Name
Lovato Amanda
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Overexpression of PARG deregulates epigenetic modifications in breast cancer
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer; Chromatin Immunoprecipiation; Ctcf; Epigenetics; P16; Parg; Parp
Abstract
Cancer is characterized by abnormal, uncontrolled division of cells. This is the result of a change analogous to 'stepping on the accelerator', or alternatively, losing the 'brake' controlling growth. Recent evidence has shown that one of the initiating steps towards breast cancer is the loss of some of these 'brakes'. Although our DNA cannot easily be reverted to its initial condition once altered to its diseased state, a new branch of research has suggested that we can activate or inactivate targets that have been modified. Applying the knowledge of this new field, we hope to study a target (PARG) we think is highly expressed in cancer and causes the silencing/inactivation of the 'brakes' referred to above. If inhibited with a drug, PARG is likely to restore the expression of the brake, reducing cell growth and ultimately help increase breast cancer survival.
Competitiondate
201202
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lovato, Amanda
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~